HHS-OIG HHS OIG’s Mary Riordan Outlines New Compliance Priorities at Compliance… Thomas Sullivan Nov 7, 2024 0 Mary Riordan, Senior Counsel at the US Health and Human Services Office of Inspector General (HHS-OIG) provided significant…
CMS CMS Releases Prices for Inflation Reduction Act Drug Price Negotiation… Thomas Sullivan Oct 23, 2024 0 On Thursday, August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) released the prices for the first 10…
Drug Prices The Inflation Reduction Act (IRA) and Its Broader Impact on Innovation,… Thomas Sullivan Oct 21, 2024 0 On October 8, 2024, PhRMA held a media briefing to address growing concerns over the Inflation Reduction Act (IRA) and its effects…
Uncategorized CBO Report: Prices for and Spending on Specialty Drugs in Medicare Part D… Thomas Sullivan Apr 23, 2019 0 A new Congressional Budget Office report Prices for and Spending on Specialty Drugs in Medicare Part D and Medicaid finds that net…
Congress Senate Aging Committee on Pharmaceutical Pricing Thomas Sullivan Mar 23, 2010 0 At the Senate Special Committee on Aging Hearing last week, Senators focused on “Seniors Feeling the Squeeze: Rising Drug Prices…
Congress Congressional Hearing – Prescription Drug Price Inflation: Are Prices… Thomas Sullivan Dec 9, 2009 0 The House Subcommittee on Health (of the House Energy and Commerce Committee) recently held a hearing titled "Prescription Drug…